Alchemia closes over-subscribed share offer

Company News

Alchemia Limited (ASX:ACL) has successfully closed a heavily over-subscribed share purchase plan, raising $2.75 million after scaling back demand.

The new capital adds to a recent $10.2 million institutional placement, with a total allotment of 9.1 million shares at 30 cents each.

Chairman Dr Mel Bridges says the outstanding shareholder response ensures Alchemia has sufficient capital to fund a pivotal phase three trial of a lead therapeutic and platform technology. 

Dr Bridges says the over subscription indicates investor acknowledgement of the near term potential of the technology and further endorses Alchemia’s longer term commercial prospects.

Alchemia reported a net loss of $5.9 million in the first half of fiscal 2013. 

Are you a 708 sophisticated investor?

A sophisticated investor is defined under Section 708 of the Corporations Act (net assets of $2.5 million or annual incomes in excess of $250,000).

They are eligible to receive information regarding wholesale investment opportunities that are not available to regular or retail investors.

Please subscribe if you would like to be alerted to these types of opportunities.